Literature DB >> 16186314

Use of insulin glargine during pregnancy in seven type 1 diabetic women.

Jorien M Woolderink, Aren J van Loon, Fred Storms, Loek de Heide, Klaas Hoogenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16186314     DOI： 10.2337/diacare.28.10.2594

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  The insulin analog glargine during an unplanned pregnancy.

Authors:  Daniela Cechurová; Silvie Lacigová; Zdenĕk Jankovec; Iva Haladová; Michal Zourek; Michal Krcma; Zdenĕk Rusavý; Jirí Turek
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

Review 2.  Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.

Authors:  Ruth Martis; Caroline A Crowther; Emily Shepherd; Jane Alsweiler; Michelle R Downie; Julie Brown
Journal:  Cochrane Database Syst Rev       Date:  2018-08-14

3.  Perinatal outcomes associated with the use of glargine during pregnancy.

Authors:  G Di Cianni; E Torlone; C Lencioni; M Bonomo; A Di Benedetto; A Napoli; E Vitacolonna; D Mannino; A Lapolla
Journal:  Diabet Med       Date:  2008-08       Impact factor: 4.359

Review 4.  A review of current treatment strategies for gestational diabetes mellitus.

Authors:  Kristi W Kelley; Dana G Carroll; Allison Meyer
Journal:  Drugs Context       Date:  2015-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.